Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2010
06/24/2010US20100160608 Protein stabilizer
06/24/2010US20100160607 p16 MEDIATED REGULATION OF NMDA RECEPTORS
06/24/2010US20100160467 Organic-inorganic hybrid scaffolds with surface-immobilized nano-hydroxyapatite and preparation method thereof
06/24/2010US20100160420 Novel simian t-cell lymphotropic virus
06/24/2010US20100160238 TGFP-CAP Peptide and its Uses
06/24/2010US20100160236 Method for Preventing Formation of Trisulfide Derivatives of Polypeptides
06/24/2010US20100160235 Fgf homologs compositions and uses thereof
06/24/2010US20100160234 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications
06/24/2010US20100160231 Axmi-150 delta-endotoxin gene and methods for its use
06/24/2010US20100160228 Method for inhibiting or stimulating angiogenesis in an individual
06/24/2010US20100160227 Signaling peptides
06/24/2010US20100160226 Y-receptor agonists
06/24/2010US20100160225 Lefty, lefty derivatives and uses thereof
06/24/2010US20100160222 Treatment of Psoriasis through Down-Regulation of the EGF-Receptor with Topically Applied EGF
06/24/2010US20100160221 Effect of tula on hiv
06/24/2010US20100160220 Compositions and Methods for Improving Bone Mass Through Modulation of Novel Receptors of PTH and Fragments Thereof
06/24/2010US20100160219 Novel Polypeptides Inducing Dendritic Cell Migration, as Well as Medicines and Pharmaceutical Compositions Containing Same
06/24/2010US20100160217 Acetylycholine gated ion channel chaperons and methods of using the same
06/24/2010US20100160212 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
06/24/2010US20100160209 Composition and Method for Increasing Cell Permeability of a Compound
06/24/2010US20100160208 Pharmaceutical composition
06/24/2010US20100160180 Crystal Structure of an Angiotensin-Converting Enzyme (ACE) and Uses Thereof
06/24/2010US20100160174 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
06/24/2010US20100159541 Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium
06/24/2010US20100159534 Recombinant Type II Restriction Endonuclease, NmeAIII, and a Process for Producing the Same
06/24/2010US20100159511 Production of recombinant selenoprotein mutants with enhanced catalytic activity
06/24/2010US20100159477 Reagents for the detection of protein phosphorylation in signaling pathways
06/24/2010US20100159473 Peptide Standards
06/24/2010US20100159467 Method for replicating the hepatitis c virus
06/24/2010US20100159465 Screening of Abundantly Secreted Proteins and Their Use as Fusion Partners for the Production of Recombinant Proteins
06/24/2010US20100159453 Genes involved in intestinal inflammatory diseases and use thereof
06/24/2010US20100159442 Magnetic recognition system
06/24/2010US20100159070 Alcohol Acetyl Transferase Gene and Use Thereof
06/24/2010US20100159006 Improved antimicrobial peptides
06/24/2010US20100158975 Extracellular matrix compositions
06/24/2010US20100158955 Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity
06/24/2010US20100158942 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
06/24/2010US20100158938 Tetravalent Dengue Vaccines
06/24/2010US20100158936 Immunostimulatory compositions and methods
06/24/2010US20100158935 Mutant forms of streptolysin o
06/24/2010US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
06/24/2010US20100158932 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
06/24/2010US20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases
06/24/2010US20100158918 Polypeptides and polynucleotides encoding same
06/24/2010US20100158917 Methods for diagnosing cancer and decreasing metastasis by cancer cells
06/24/2010US20100158912 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence
06/24/2010US20100158911 Compositions and Methods of Treating Disease with FGFR Fusion Proteins
06/24/2010US20100158907 Connective tissue growth factor fragments and methods and uses thereof
06/24/2010US20100158892 Pest control
06/24/2010US20100158867 Paramyxovirus vector encoding angiogenesis gene and use thereof
06/24/2010US20100158847 Hair-binding peptides
06/24/2010US20100158846 Hair-binding peptides
06/24/2010US20100158837 Iron oxide-binding peptides
06/24/2010US20100158823 Peptide linkers for effective multivalent peptide binding
06/24/2010US20100158814 Fibrin-Binding Peptides and Conjugates Thereof
06/24/2010US20100158809 Truncated pap2 and methods of making and using same
06/24/2010US20100158807 Receptor
06/24/2010US20100155245 Thrombospondin Fragments and Binding Agents in the Detection, Diagnosis and Evaluation of Cancer
06/24/2010DE102004062386B4 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes
06/24/2010DE102004044421B4 Verfahren zur Trennung eines von Willebrand Faktors mit einer spezifischen VWF-Aktivität von wenigstens 50 E/mg VWF-Antigen von einem von Willebrand Faktor mit niedriger Aktivität und Verwendung von Hydroxylapatit dafür Process for the separation of a von Willebrand factor with a specific VWF activity of at least 50 U / mg VWF antigen of a von Willebrand factor with low activity and use of hydroxyapatite for
06/24/2010CA2747678A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
06/24/2010CA2747220A1 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
06/24/2010CA2747197A1 Glucagon analogues
06/24/2010CA2747155A1 Glucagon analogues
06/24/2010CA2747112A1 Glucagon analogues
06/24/2010CA2747109A1 Glucagon analogues
06/24/2010CA2745747A1 Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same
06/24/2010CA2745522A1 Method for extracting hydrophobin from a solution
06/24/2010CA2744310A1 Bidirectional promoter from z. mais
06/24/2010CA2706317A1 Doc1 compositions and methods for treating cancer
06/23/2010EP2199397A2 Plants having modified growth characteristics and a method for making the same
06/23/2010EP2199393A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
06/23/2010EP2199391A1 Factor involved in latent infection with herpesvirus, and use thereof
06/23/2010EP2199385A1 Specific and persistent activation of heat shock response in cell lines using a viral factor
06/23/2010EP2199305A1 Peptides against autoantibodies associated with CRPS and use of these peptides
06/23/2010EP2199304A1 Process for the control of production of fine chemicals
06/23/2010EP2199303A1 Polypeptides and method for specific metering of antibodies for patients with a borrelia infection
06/23/2010EP2199301A1 Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or fragment thereof
06/23/2010EP2198890A1 Combinatorial libraries of monomer domains
06/23/2010EP2198877A2 Orally administered peptides to ameliorate atherosclerosis
06/23/2010EP2198876A1 A method for reducing the likelihood of implantation failure in a subject
06/23/2010EP2198875A1 A method for reducing the likelihood of preterm labour in a subject in need thereof
06/23/2010EP2198304A2 Molecules and methods for treatment and detection of diabetes
06/23/2010EP2198028A2 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease
06/23/2010EP2198022A1 Designed armadillo repeat proteins
06/23/2010EP2198016A1 Porcine adeno-associated viruses
06/23/2010EP2197910A2 Modified t cell receptors and related materials and methods
06/23/2010EP2197909A2 Receptor-targeting reagents
06/23/2010EP2197906A1 Fusion polypeptide comprising s-antigen repeat units
06/23/2010EP2197903A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity
06/23/2010EP2197902A1 Method for the recombinant production of magnetic nanoparticles
06/23/2010EP2197901A1 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap
06/23/2010EP2197900A2 Mutant double cyclized receptor peptides inhibiting 1-adrenoceptor antibodies
06/23/2010EP2197484A2 Compositions comprising pneumococcal antigens
06/23/2010EP2197482A2 S-layer protein of a. hydrophila as vaccine in fish
06/23/2010EP2197468A1 Pegylation by the dock and lock (dnl) technique
06/23/2010EP2197459A1 A lung-surfactant product
06/23/2010EP1670309B1 Transgenic animals with serious disorders related to alzheimer's disease
06/23/2010EP1425423B1 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
06/23/2010EP1400550B1 Branched polyalkylene glycols
1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 2916